New Medicare Coverage for Fluoro-Deoxy Glucose PET Scans for Dementia and Neurodegenerative Diseases

Summary

The US Department of Health and Human Services (HHS) is proposing to cover Fluoro-Deoxy Glucose (FDG) Positron Emission Tomography (PET) scans for dementia and neurodegenerative diseases (DND) under Medicare, subject to certain safeguards for patients, following a review of the evidence that found sufficient benefit in differential diagnosis of fronto-temporal dementia.